Press Release: Simcere Pharmaceutical Group – Wed, Apr 3, 2013 6:00 AM EDT
NANJING, China, April 3, 2013 /PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company") (SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that its Special Committee of the Board of Directors (the "Special Committee"), which was formed to consider a proposal by Mr. Jinsheng Ren, New Good Management Limited, Assure Ahead Investments Limited and its affiliates (the "Buyer Group"), pursuant to which the Buyer Group proposes to acquire all of the outstanding ordinary shares of the Company not currently owned by the Buyer Group, and any potential alternative transactions involving the Company, has retained UBS AG and/or its affiliates as its exclusive financial advisor to assist it in its work. No decisions have been made by the Special Committee with respect to the Company's response to the proposed transaction. There can be no assurance that any definitive offer will be made, that any agreement will be executed or that this or any other transaction will be approved or consummated.
Recent SCR News
- /C O R R E C T I O N from Source -- Strathcona Resources Ltd./ • PR Newswire (US) • 04/15/2024 10:35:00 PM
- Strathcona Announces Q1 2024 Conference Call • PR Newswire (Canada) • 04/15/2024 09:51:00 PM
- Strathcona Announces Q1 2024 Conference Call • PR Newswire (US) • 04/15/2024 09:51:00 PM
- Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2023 Financial and Operating Results • PR Newswire (Canada) • 03/26/2024 11:47:00 PM
- Strathcona Resources Ltd. Reports Fourth Quarter and Full Year 2023 Financial and Operating Results • PR Newswire (US) • 03/26/2024 11:47:00 PM
- Strathcona Resources Ltd. Reports Year End 2023 Reserves • PR Newswire (US) • 03/12/2024 02:07:00 AM
- Strathcona Resources Ltd. Reports Year End 2023 Reserves • PR Newswire (Canada) • 03/12/2024 02:07:00 AM
- Strathcona Announces Q4 2023 Conference Call • PR Newswire (US) • 02/08/2024 10:18:00 PM
- Strathcona Announces Q4 2023 Conference Call • PR Newswire (Canada) • 02/08/2024 10:18:00 PM
- Strathcona Resources Ltd. Reports Third Quarter 2023 Results and Announces 2023 and 2024 Guidance • PR Newswire (US) • 11/13/2023 11:30:00 PM
- Strathcona Resources Ltd. Reports Third Quarter 2023 Results and Announces 2023 and 2024 Guidance • PR Newswire (Canada) • 11/13/2023 11:30:00 PM
- Strathcona Resources Ltd. Announces Q3 2023 Conference Call • PR Newswire (US) • 10/19/2023 08:34:00 PM
- Strathcona Resources Ltd. Announces Q3 2023 Conference Call • PR Newswire (Canada) • 10/19/2023 08:34:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM